Great Point Partners’s ProMIS Neurosciences PMN Stock Holding History

Great Point Partners’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	86,150 -285,252	-77%	-$3.1M	0.21%	42
2026 Q1	$4.72M	Buy	+371,402	New	+$5.54M	1.08%	32
2025 Q3	–	Sell	-105,805	Closed	-$1.28M	–	36
2025 Q2	$1.28M	Hold	105,805	–	–	0.83%	24
2025 Q1	$1.84M	Hold	105,805	–	–	0.97%	30
2024 Q4	$2.51M	Sell	105,805 -5,823	-5%	-$145K	1.18%	24
2024 Q3	$3.49M	Buy	+111,628	New	+$4.17M	1.03%	27

Other funds holding PMN

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ABG

Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Great Point Partners's PMN Position: Q2 2026 in Review

Great Point Partners reduced its ProMIS Neurosciences (PMN) stake by 77% in Q2 2026, selling an estimated $3.1M and leaving 86,150 shares worth $1.13M. The position accounts for 0.21% of the portfolio, ranked #42.

Great Point Partners first reported a position in PMN in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.72M in Q1 2026. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

Great Point Partners held 86,150 shares of ProMIS Neurosciences worth $1.13M as of Q2 2026.
Great Point Partners sold 285,252 ProMIS Neurosciences shares in Q2 2026, an estimated $3.1M.
ProMIS Neurosciences made up 0.21% of Great Point Partners's portfolio in Q2 2026, its #42 holding.
Great Point Partners first reported a position in ProMIS Neurosciences in Q3 2024 and has held it in 6 quarters since.
Great Point Partners's ProMIS Neurosciences position peaked at $4.72M in Q1 2026.
27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Great Point Partners's 13F filing for Q2 2026, filed 14 Aug 2026.